Literature DB >> 15069620

Acetaldehyde accumulation suppresses Kupffer cell release of TNF-Alpha and modifies acute hepatic inflammation in rats.

Yuji Nakamura1, Hirokazu Yokoyama, Susumu Higuchi, Sachiko Hara, Shinzo Kato, Hiromasa Ishii.   

Abstract

BACKGROUND: Alcohol-related diseases have multiple and varied associations with acetaldehyde, a highly toxic product of ethanol oxidation that accumulates in the absence of active aldehyde dehydrogenase (ALDH). This study was designed to clarify the role of acetaldehyde in liver injury, specifically in vivo and in vitro effects on Kupffer cell release of the inflammatory cytokine tumor necrosis factor-alpha (TNF-Alpha).
METHODS: Rats pretreated overnight with the ALDH inhibitor disulfiram (or saline control) were ethanol loaded and challenged with lipopolysaccharide (LPS), and their blood and histological parameters were examined 3 h later. Similarly, isolated rat Kupffer cells were pretreated with disulfiram or cyanamide incubated in ethanol (1 h), then challenged with LPS and evaluated 2 h later for TNF-Alpha and acetaldehyde levels in the culture medium. TNF-Alpha release from Kupffer cells after LPS challenge was also evaluated following incubation in acetaldehyde and acetate for comparison with ethanol loading.
RESULTS: Higher blood acetaldehyde concentration following disulfiram pretreatment significantly attenuated acute hepatic inflammation in the ethanol-loaded, LPS-challenged rat (18 +/- 2.9 vs 30 +/- 3.7 polymorphonuclear cells/portal area; P = 0.01). After LPS challenge, ALDH inhibitor pretreatment attenuated Kupffer cell release of TNF-Alpha in the presence of disulfiram at 5063 +/- 151 pg/ml and cyanamide at 4390 +/- 934 pg/ml, versus no inhibitor, 5869 +/- 265 pg/ml ( P < 0.01), but not in the absence of ethanol. Acetaldehyde significantly suppressed Kupffer cell TNF-Alpha release ( P < 0.05), but acetate treatment did not.
CONCLUSIONS: Acetaldehyde accumulation suppresses macrophage function, at least suppressing TNF-Alpha release, which plays a role in modifying acute hepatic inflammation in rats.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15069620     DOI: 10.1007/s00535-003-1278-5

Source DB:  PubMed          Journal:  J Gastroenterol        ISSN: 0944-1174            Impact factor:   7.527


  7 in total

Review 1.  Immunological response in alcoholic liver disease.

Authors:  Michael J Duryee; Lynell W Klassen; Geoffrey M Thiele
Journal:  World J Gastroenterol       Date:  2007-10-07       Impact factor: 5.742

2.  Drug interaction between ethanol and 3,4-methylenedioxymethamphetamine ("ecstasy").

Authors:  Vijay V Upreti; Natalie D Eddington; Kwan-Hoon Moon; Byoung-Joon Song; Insong J Lee
Journal:  Toxicol Lett       Date:  2009-04-05       Impact factor: 4.372

3.  Acetaldehyde stimulates monocyte adhesion in a P-selectin- and TNFalpha-dependent manner.

Authors:  Eileen M Redmond; David Morrow; Sreenath Kundimi; Carol L Miller-Graziano; John P Cullen
Journal:  Atherosclerosis       Date:  2008-10-18       Impact factor: 5.162

4.  Accumulation of acetaldehyde in aldh2.1-/- zebrafish causes increased retinal angiogenesis and impaired glucose metabolism.

Authors:  David Philipp Wohlfart; Bowen Lou; Chiara Simone Middel; Jakob Morgenstern; Thomas Fleming; Carsten Sticht; Ingrid Hausser; Rüdiger Hell; Hans-Peter Hammes; Julia Szendrödi; Peter Paul Nawroth; Jens Kroll
Journal:  Redox Biol       Date:  2022-01-26       Impact factor: 11.799

5.  Peroxisome proliferator-activated receptor and retinoic x receptor in alcoholic liver disease.

Authors:  Tommaso Mello; Simone Polvani; Andrea Galli
Journal:  PPAR Res       Date:  2009-09-14       Impact factor: 4.964

6.  Acetaldehyde exposure underlies functional defects in monocytes induced by excessive alcohol consumption.

Authors:  Shunsuke Shiba; Nobuhiro Nakamoto; Po-Sung Chu; Keisuke Ojiro; Nobuhito Taniki; Akihiro Yamaguchi; Rei Morikawa; Tadashi Katayama; Aya Yoshida; Ryo Aoki; Toshiaki Teratani; Takahiro Suzuki; Takeshi Miyamoto; Sachiko Hara; Akira Yokoyama; Takanori Kanai
Journal:  Sci Rep       Date:  2021-07-01       Impact factor: 4.379

7.  Akt1 and Akt2 Isoforms Play Distinct Roles in Regulating the Development of Inflammation and Fibrosis Associated with Alcoholic Liver Disease.

Authors:  Karina Reyes-Gordillo; Ruchi Shah; Jaime Arellanes-Robledo; Ying Cheng; Joseph Ibrahim; Pamela L Tuma
Journal:  Cells       Date:  2019-10-29       Impact factor: 6.600

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.